| Product Information |
BR-1321_PI_01.pdf
|
| Registration Number |
BR-1321
|
| Generic Name |
Botulinum Toxin Type A
|
| Brand Name |
Nabota
|
| Dosage Strength |
200 Units
|
| Dosage Form |
Lyophilized Powder for Solution for Injection (IM/SC)
|
| Classification |
Prescription Drug (RX)
|
| Packaging |
USP Type O borosilicate glass vial enclosed with chlorobutyl rubber stopper, crimped with aluminum seal and orange polypropylene cap (Box of 1's)
|
| Pharmacologic Category |
-
|
| Manufacturer |
Daewoong Pharmaceutical Co., Ltd.
|
| Country of Origin |
Korea
|
| Trader |
|
| Importer |
Daewoong Pharma Philippines, Incorporated
|
| Distributor |
|
| Application Type |
Monitored Release
|
| Issuance Date |
16 June 2020
|
| Expiry Date |
16 June 2025
|